External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AANEM 2025

-
Coming soon
01:15 AM
Duration 24hrs San Francisco, USA
A long-term follow-up study of risdiplam▼ (WeSMA study): Interim results in adult participants with SMA
Abdul Hamid, K Arya, S Bernes, JL Chinarian, CA Chiriboga, AK Daunter, S Dixon, A Kumar, S Ladha, SE Matesanz, LM Ramos-Platt, RC Richardson, ​RJ Scharf, MD Svoboda, DN Toupin, AS Varadhachary, V Vedanarayanan, SE Wright, I Tanvir, E Lim, E Keto, S Shapouri, R Shah, G Seth​

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar